Advertisement
Most Americans report having excellent or good health and have a usual place to go for medical care

CDC: Most Americans Report Excellent, Good Health

0
Most health measures remained stable from 2017; percent of adults who have been tested for HIV increased
The U.S. Food and Drug Administration will temporarily be overseen by the head of the National Cancer Institute when FDA Commissioner Scott Gottlieb

Head of National Cancer Institute Named Acting FDA Commissioner

0
Current commissioner, Scott Gottlieb, will be stepping down in April
Acupressure is associated with improvements in co-occurring symptoms in breast cancer survivors with fatigue

Acupressure Reduces Lasting Symptoms in Breast Cancer Survivors

0
Tied to improvements in pain, anxiety, depression among breast cancer survivors with fatigue
Atopic dermatitis is associated with increased depression and anxiety

Anxiety, Depression More Likely for Adults With Atopic Dermatitis

0
Individuals with AD more likely to have been diagnosed with anxiety or depression in past year
For veterans enrolled in the U.S. Department of Veterans Affairs (VA) and Medicare Part D

Dual Receipt of Opioids Tied to Increased Risk for OD Death

0
Those enrolled in both VA and Medicare Part D have higher odds of death from Rx opioid overdose
Treatment with dasotraline (4 mg/day) significantly improves attention-deficit/hyperactivity disorder symptoms in children aged 6 to 12 years

Dasotraline Promising for the Treatment of ADHD in Children

0
Once-daily dosing tolerable, may lessen side effects
Approximately one in five individuals may develop mental health symptoms up to six months after mild traumatic brain injury

Mental Health Symptoms Common After Mild Brain Injury

0
Authors say findings show importance of follow-up care after emergency department visit
Only 16 percent of seniors receive regular cognitive assessments

Few Seniors Receive Regular Brief Cognitive Assessments

0
Report also reveals number of seniors living with Alzheimer disease projected to increase
The U.S. Food and Drug Administration on Tuesday approved the nasal spray medication esketamine -- a relative of the club drug and anesthetic ketamine -- for use against severe depression. Sold as Spravato

FDA Approves Ketamine-Like Drug for Severe Depression

0
Drug available through restricted distribution system, must be administered in certified medical office
For overweight adults with depression

Studies Look at Ways to Reduce Depressive Episodes in Obese

0
Integrated intervention associated with decline in body mass index, depressive symptoms